The vaccine was found to be about 27% more effective than the standard flu shot in a late-stage trial. The FDA and the CDC still must sign off on the vaccine before it’s available. The vaccine was found to be about 27% more effective than the standard flu shot in a late-stage trial. The FDA and the CDC still must sign off on the vaccine before it’s available.
FDA panel recommends Moderna’s mRNA flu shot for older adultsFDA panel recommends Moderna’s mRNA flu shot for older adults
